Health Jun 05 Mark Cuban aims to lower prescription drug prices with online pharmacy By Geoff Bennett, Andrew Corkery, Juliet Fuisz
Health Jan 09 California could be 1st state to sell its own prescription drugs The Democratic governor wants the nation's most populous state to contract with generic drug companies to make medications on its behalf so it could sell them to its nearly 40 million residents. By Adam Beam, Associated Press
Health May 15 Watch 5:44 Conn. attorney general calls generic drug makers a ‘private sector cartel’ Affordable health care is a persistent concern for Americans and a topic of great political debate. Typically, generic prescription drugs offer a cheaper alternative to name brands, but a new multi-state lawsuit alleges that their manufacturers have been artificially raising…
Health May 15 Watch 4:20 How generic drug makers are responding to price-fixing lawsuit U.S. consumers often turn to generic versions of prescription drugs to keep costs down, but dozens of states are now suing manufacturers of these drugs, saying they illegally fixed prices and divided up market share. Affected drugs include medicines used…
Health Sep 21 Mylan CEO defends EpiPen cost to angry lawmakers The head of pharmaceutical company Mylan is defending the cost for life-saving EpiPens, signaling the company has no plans to lower prices despite a public outcry and questions from skeptical lawmakers. By Mary Clare Jalonick, Associated Press
Aug 29 Watch 7:41 Did outcry on social media lead to Mylan’s generic EpiPen? By PBS NewsHour After news broke that the price of EpiPen injectors has skyrocketed, the allergy medicine’s maker, Mylan, announced its intention to offer a generic version of the product, to be sold at half the market price of the original. The New… Continue watching
Jun 05 Watch 9:34 What’s delaying some generic drugs from coming to market? By PBS NewsHour The Federal Trade Commission's recent $1.2 billion settlement over the drug Provigil has brought so-called "pay for delay" deals for generic drugs back into the spotlight. Opponents say these deals delay generic medications to market, costing consumers billions. But drug… Continue watching
Apr 20 Drugmaker settles for $512 million in suit over delayed generics By Megan Thompson Pharmaceutical maker Teva has agreed to a settlement of $512 million in a class action lawsuit over the wakefulness drug Provigil. Drug wholesalers and retailers claimed a generic version of the drug was delayed to market by so-called “pay for… Continue reading
Mar 08 FDA approves first biosimilar drug for distribution in the U.S. By Triana Kalmanoff The Food and Drug Administration has approved the first biosimilar drug for distribution in the United States, the agency announced on Friday. Continue reading
Sep 19 When will your prescriptions be cheaper? By Making Sen$e Editor We all know generics are cheaper. But how much cheaper? Economists find a 38 to 48 percent decline in the prices of physician-administered drugs after the drugs' patents have expired. The decline is slightly lower for oral drugs. Continue reading